Gerresheimer reports lower half-year core profit

By Reuters News

- Drug-packaging maker Gerresheimer GXIG.DE reported a lower core profit for the first half of 2026 on Wednesday, as weakness in its Moulded Glass business and lower demand for injection vials weighed on performance.

The German company reported preliminary half-year earnings before interest, taxes, depreciation and amortisation of €168 million ($191 million), compared with €210.4 million a year ago.

($1 = 0.8811 euros)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk